BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Rexahn Pharmaceuticals, Inc. 

15245 Shady Grove Road
Suite 455
Rockville  Maryland  20850  U.S.A.
Phone: 240-268-5300 Fax: 240-268-5310


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Rexahn Pharmaceuticals, Inc. (RNN) To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/30/2014 7:19:43 AM
Rexahn Pharmaceuticals, Inc. (RNN) Receives FDA Orphan Drug Designation For RX-3117 In Treatment Of Pancreatic Cancer 9/25/2014 7:51:44 AM
Rexahn Pharmaceuticals, Inc. (RNN)To Present At The 14th Annual Biotech In Europe Investor Forum For Global Partnering And Investment In Basel, Switzerland 9/23/2014 8:27:31 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The BioPharm America™ 2014 In Boston, Massachusetts, USA 9/16/2014 11:26:15 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference On September 9, 2014 9/4/2014 10:42:14 AM
Rexahn Pharmaceuticals, Inc. (RNN) Receives A Notice Of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted Cancer Drug Delivery Platform 9/3/2014 8:41:13 AM
Rexahn Pharmaceuticals, Inc. (RNN) Reports Second Quarter 2014 Financial Results And Pipeline Update 8/14/2014 8:11:43 AM
Rexahn Pharmaceuticals, Inc. (RNN) Provides Update On Phase I Supinoxin Trial In Cancer Patients With Solid Tumors 7/18/2014 10:47:19 AM
Rexahn Pharmaceuticals, Inc. (RNN) Reports First Quarter 2014 Financial Results And Pipeline Update 5/15/2014 9:56:42 AM
Rexahn Pharmaceuticals, Inc. (RNN) Announces Additional Data From Preclinical Studies Of RX-3117 5/8/2014 10:57:18 AM
12345678910...